Literature DB >> 18561654

Prostate intrafraction motion evaluation using kV fluoroscopy during treatment delivery: a feasibility and accuracy study.

Justus Adamson1, Qiuwen Wu.   

Abstract

Margin reduction for prostate radiotherapy is limited by uncertainty in prostate localization during treatment. We investigated the feasibility and accuracy of measuring prostate intrafraction motion using kV fluoroscopy performed simultaneously with radiotherapy. Three gold coils used for target localization were implanted into the patient's prostate gland before undergoing hypofractionated online image-guided step-and-shoot intensity modulated radiation therapy (IMRT) on an Elekta Synergy linear accelerator. At each fraction, the patient was aligned using a cone-beam computed tomography (CBCT), after which the IMRT treatment delivery and fluoroscopy were performed simultaneously. In addition, a post-treatment CBCT was acquired with the patient still on the table. To measure the intrafraction motion, we developed an algorithm to register the fluoroscopy images to a reference image derived from the post-treatment CBCT, and we estimated coil motion in three-dimensional (3D) space by combining information from registrations at different gantry angles. We also detected the MV beam turning on and off using MV scatter incident in the same fluoroscopy images, and used this information to synchronize our intrafraction evaluation with the treatment delivery. In addition, we assessed the following: the method to synchronize with treatment delivery, the dose from kV imaging, the accuracy of the localization, and the error propagated into the 3D localization from motion between fluoroscopy acquisitions. With 0.16 mAs/frame and a bowtie filter implemented, the coils could be localized with the gantry at both 0 degrees and 270 degrees with the MV beam off, and at 270 degrees with the MV beam on when multiple fluoroscopy frames were averaged. The localization in two-dimensions for phantom and patient measurements was performed with submillimeter accuracy. After backprojection into 3D the patient localization error was (-0.04 +/- 0.30) mm, (0.09 +/- 0.36)mm, and (0.03 +/- 0.68)mm in the right-left (RL), anterior-posterior (AP), and superior-inferior (SI) axes, respectively. Simulations showed that while oscillating (stationary) motion cannot be effectively represented in 3D, linearly drifting (nonstationary) motion is detectable with good accuracy. These results show that measuring prostate intrafraction motion using a single kV imager during radiotherapy is feasible and can be performed with acceptable accuracy.

Entities:  

Mesh:

Year:  2008        PMID: 18561654      PMCID: PMC2507873          DOI: 10.1118/1.2899998

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  36 in total

1.  Characterization of a fluoroscopic imaging system for kV and MV radiography.

Authors:  D G Drake; D A Jaffray; J W Wong
Journal:  Med Phys       Date:  2000-05       Impact factor: 4.071

2.  Cone-beam computed tomography with a flat-panel imager: initial performance characterization.

Authors:  D A Jaffray; J H Siewerdsen
Journal:  Med Phys       Date:  2000-06       Impact factor: 4.071

3.  Measurements and clinical consequences of prostate motion during a radiotherapy fraction.

Authors:  Aart J Nederveen; Uulke A van der Heide; Homan Dehnad; R Jeroen A van Moorselaar; Pieter Hofman; Jan J W Lagendijk
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-05-01       Impact factor: 7.038

4.  Experience of ultrasound-based daily prostate localization.

Authors:  Anurag Chandra; Lei Dong; Eugene Huang; Deborah A Kuban; Laura O'Neill; Isaac Rosen; Alan Pollack
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-06-01       Impact factor: 7.038

5.  Robustness and precision of an automatic marker detection algorithm for online prostate daily targeting using a standard V-EPID.

Authors:  S Aubin; L Beaulieu; S Pouliot; J Pouliot; R Roy; L M Girouard; N Martel-Brisson; E Vigneault; J Laverdière
Journal:  Med Phys       Date:  2003-07       Impact factor: 4.071

6.  Flat-panel cone-beam computed tomography for image-guided radiation therapy.

Authors:  David A Jaffray; Jeffrey H Siewerdsen; John W Wong; Alvaro A Martinez
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-08-01       Impact factor: 7.038

7.  Intrafraction prostate motion during IMRT for prostate cancer.

Authors:  Eugene Huang; Lei Dong; Anurag Chandra; Deborah A Kuban; Isaac I Rosen; Anissa Evans; Alan Pollack
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-06-01       Impact factor: 7.038

8.  Three-dimensional intrafractional movement of prostate measured during real-time tumor-tracking radiotherapy in supine and prone treatment positions.

Authors:  Kei Kitamura; Hiroki Shirato; Yvette Seppenwoolde; Rikiya Onimaru; Makoto Oda; Katsuhisa Fujita; Shinichi Shimizu; Nobuo Shinohara; Toru Harabayashi; Kazuo Miyasaka
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-08-01       Impact factor: 7.038

9.  Comparison of megavoltage position verification for prostate irradiation based on bony anatomy and implanted fiducials.

Authors:  Aart J Nederveen; Homan Dehnad; Uulke A van der Heide; R Jeroen A van Moorselaar; Pieter Hofman; Jan J W Lagendijk
Journal:  Radiother Oncol       Date:  2003-07       Impact factor: 6.280

10.  Intrafraction motion of the prostate during external-beam radiation therapy: analysis of 427 patients with implanted fiducial markers.

Authors:  Alexis N T J Kotte; Pieter Hofman; Jan J W Lagendijk; Marco van Vulpen; Uulke A van der Heide
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-05-21       Impact factor: 7.038

View more
  20 in total

1.  Evaluations of an adaptive planning technique incorporating dose feedback in image-guided radiotherapy of prostate cancer.

Authors:  Han Liu; Qiuwen Wu
Journal:  Med Phys       Date:  2011-12       Impact factor: 4.071

2.  Feasibility of low-dose single-view 3D fiducial tracking concurrent with external beam delivery.

Authors:  Michael A Speidel; Brian P Wilfley; Annie Hsu; Dimitre Hristov
Journal:  Med Phys       Date:  2012-04       Impact factor: 4.071

3.  Dosimetric effect of intrafraction motion and residual setup error for hypofractionated prostate intensity-modulated radiotherapy with online cone beam computed tomography image guidance.

Authors:  Justus Adamson; Qiuwen Wu; Di Yan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-06-18       Impact factor: 7.038

4.  Prostate intrafraction motion assessed by simultaneous kilovoltage fluoroscopy at megavoltage delivery I: clinical observations and pattern analysis.

Authors:  Justus Adamson; Qiuwen Wu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-06-25       Impact factor: 7.038

5.  Marker-free lung tumor trajectory estimation from a cone beam CT sinogram.

Authors:  Geoffrey D Hugo; Jian Liang; Di Yan
Journal:  Phys Med Biol       Date:  2010-04-14       Impact factor: 3.609

6.  Prostate intrafraction motion assessed by simultaneous kV fluoroscopy at MV delivery II: adaptive strategies.

Authors:  Justus Adamson; Qiuwen Wu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-06-26       Impact factor: 7.038

7.  Optimizing monoscopic kV fluoro acquisition for prostate intrafraction motion evaluation.

Authors:  Justus Adamson; Qiuwen Wu
Journal:  Phys Med Biol       Date:  2008-12-10       Impact factor: 3.609

8.  Inferences about prostate intrafraction motion from pre- and posttreatment volumetric imaging.

Authors:  Justus Adamson; Qiuwen Wu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-06-08       Impact factor: 7.038

Review 9.  Hypofractionated radiotherapy for localised prostate cancer. Review of clinical trials.

Authors:  Víctor Macías; Albert Biete
Journal:  Clin Transl Oncol       Date:  2009-07       Impact factor: 3.405

10.  IMRT of prostate cancer: a comparison of fluence optimization with sequential segmentation and direct step-and-shoot optimization.

Authors:  Marius Treutwein; Matthias Hipp; Oliver Kölbl; Ludwig Bogner
Journal:  Strahlenther Onkol       Date:  2009-06-09       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.